- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Choice reaction time.
Displaying page 1 of 2.
EudraCT Number: 2004-000235-28 | Sponsor Protocol Number: 190-060 | Start Date*: 2004-10-27 |
Sponsor Name:Sepracor Inc. | ||
Full Title: The effects of a single evening dose of 3mg eszopiclone on next day driving ability and psychomotor/memory function in patients with primary insomnia compared to placebo | ||
Medical condition: Insomnia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002073-26 | Sponsor Protocol Number: 1125-ECIR | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:Medical Center - University of Freiburg | |||||||||||||||||||||||
Full Title: Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steroid-refractory immune related adverse events after immune checkpoint inhibitor therapy | |||||||||||||||||||||||
Medical condition: Immune related adverse events induced by treatment with immune checkpoint inhibitors (monoclocanl antibodies against PD-1, PD-L1 or CTLA-4) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002405-47 | Sponsor Protocol Number: The CogNaive Study | Start Date*: 2007-07-31 |
Sponsor Name:Imperial College | ||
Full Title: A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral r... | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005307-42 | Sponsor Protocol Number: S2540345 | Start Date*: 2006-01-03 |
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||
Full Title: An evaluation of the 4 mg nicotine mint lozenge for the relief of cognitive impairment associated with nicotine withdrawal. | ||
Medical condition: Nicotine dependence. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-004008-16 | Sponsor Protocol Number: 20190172 | Start Date*: 2022-01-26 | |||||||||||
Sponsor Name:Amgen, Inc. | |||||||||||||
Full Title: A Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib and Panitumumab Versus Investigator’s Choice (Trifluridine and Tipiracil, or Regorafenib) for the Treatment of Pr... | |||||||||||||
Medical condition: Previously Treated Metastatic Colorectal Cancer Subjects with KRAS p.G12C Mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DE (Restarted) GR (Trial now transitioned) ES (Ongoing) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001264-28 | Sponsor Protocol Number: P2-IMU-838-COV | Start Date*: 2020-05-28 | |||||||||||
Sponsor Name:Immunic AG | |||||||||||||
Full Title: A Prospective, Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Ca... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BG (Completed) RO (Completed) GR (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004553-72 | Sponsor Protocol Number: J2N-OX-JZNM(LOXO-BTK-20019) | Start Date*: 2021-07-14 | |||||||||||
Sponsor Name:Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company | |||||||||||||
Full Title: A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321) | |||||||||||||
Medical condition: Mantle cell lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) FR (Trial now transitioned) AT (Trial now transitioned) CZ (Trial now transitioned) DE (Trial now transitioned) PT (Trial now transitioned) HU (Completed) NL (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000230-34 | Sponsor Protocol Number: 15906A | Start Date*: 2014-09-23 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: An interventional, randomised, double-blind, parallel-group, placebo-controlled, active-referenced (paroxetine), fixed-dose study on the efficacy of vortioxetine on cognitive dysfunction in working... | |||||||||||||
Medical condition: Major depressive disorder and cognitive impairment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) FI (Completed) LT (Completed) DE (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000231-16 | Sponsor Protocol Number: 15907A | Start Date*: 2014-10-07 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: An interventional, randomised, double-blind, parallel-group, active-comparator, flexible-dose study on the efficacy of vortioxetine versus escitalopram on cognitive dysfunction in patients with ... | |||||||||||||
Medical condition: Major Depressive Disorder and cognitive impairment | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003984-37 | Sponsor Protocol Number: CMX001-211 | Start Date*: 2018-07-30 | |||||||||||
Sponsor Name:Chimerix, Inc | |||||||||||||
Full Title: A Randomized, Controlled, Open-Label, Multiple Ascending Dose Study of Intravenous Brincidofovir in Adult Allogeneic Hematopoietic Cell Transplant Recipients with Adenovirus Viremia | |||||||||||||
Medical condition: Treatment of adenovirus infections in adult allogeneic hematopoietic cell transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003117-28 | Sponsor Protocol Number: EPU-P77 | Start Date*: 2014-11-03 | ||||||||||||||||
Sponsor Name: | ||||||||||||||||||
Full Title: Can Methylphenidate (Ritalin) improve memory and attention in mild cognitive impairment? An EEG study | ||||||||||||||||||
Medical condition: memory impairment in patients with Mild Cognitive Impairment | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000564-42 | Sponsor Protocol Number: CANNA-TICS | Start Date*: 2017-06-14 | ||||||||||||||||
Sponsor Name:Hannover Medical School | ||||||||||||||||||
Full Title: A randomized multi-centre double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders (CANNA-TICS) | ||||||||||||||||||
Medical condition: Chronic tic disorders and Tourette syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-017806-36 | Sponsor Protocol Number: CRC287 | Start Date*: 2010-11-03 | |||||||||||
Sponsor Name:University of Surrey | |||||||||||||
Full Title: Effect of Vitano® on physiological and psychological responses to psychological stress assessed under laboratory conditions and in everyday life. | |||||||||||||
Medical condition: Psychological stress | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000229-19 | Sponsor Protocol Number: 15905A | Start Date*: 2014-09-19 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: An interventional, randomised, double-blind, parallel-group, placebo-controlled study on the efficacy of vortioxetine on cognitive dysfunction in patients with partial or full remission of major de... | |||||||||||||
Medical condition: Major Depressive Disorder and cognitive impairment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) DE (Completed) FI (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002038-36 | Sponsor Protocol Number: 11018 | Start Date*: 2007-02-27 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with Parkinson’s disease dementia or dementia with Lewy Bodies | |||||||||||||
Medical condition: Patients with Parkinson’s disease dementia or dementia with Lewy Bodies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) GB (Completed) AT (Completed) IT (Completed) DE (Completed) FR (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004640-78 | Sponsor Protocol Number: ITI-007-004 | Start Date*: 2007-11-13 | |||||||||||
Sponsor Name:Intra-Cellular Therapies, Inc | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, 4-way crossover study of ITI-007 in subjects with sleep maintenance insomnia | |||||||||||||
Medical condition: Sleep maintenance disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002971-18 | Sponsor Protocol Number: A00391 | Start Date*: 2005-04-29 | |||||||||||
Sponsor Name:UCB S.A. Pharma Sector | |||||||||||||
Full Title: A monocenter, double-blind, randomized trial, with two parallel groups comparing the clinical efficacy of levocetirizine 5 mg capsules and desloratadine 5 mg capsules taken once a day over 3 weeks ... | |||||||||||||
Medical condition: Adult subjects suffering from seasonal allergic rhinitis (SAR) due to grass pollen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005742-37 | Sponsor Protocol Number: 06/AN/02 | Start Date*: 2007-01-26 | |||||||||||
Sponsor Name:NHS Glasgow and Clyde / University of Glasgow | |||||||||||||
Full Title: Randomised clinical trial of the effects of total intravenous anaesthesia (TIVA: propofol) versus volatile anaesthesia (sevoflurane-N20 induction and isoflurane-N20 maintenance) on children’s post... | |||||||||||||
Medical condition: Dental caries | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004244-37 | Sponsor Protocol Number: 13HH1824 | Start Date*: 2014-02-21 | |||||||||||
Sponsor Name:Imperial College London | Imperial College NHS Healthcare Trust | |||||||||||||
Full Title: The control of brain networks after traumatic brain injury: a neuroimaging and neuropsychological study of dopamine and cognition | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001725-27 | Sponsor Protocol Number: KKSH152 | Start Date*: 2019-10-24 | |||||||||||
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | |||||||||||||
Full Title: A randomized, open, three-arm comparative study of modern methods of postoperative pain therapy in patients with knee endoprostheses. | |||||||||||||
Medical condition: Postoperative pain therapy after implantation of a knee endoprosthesis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
